Topical Ibuprofen for Delayed Onset Mulscle Soreness

PHASE3CompletedINTERVENTIONAL
Enrollment

205

Participants

Timeline

Start Date

June 13, 2013

Primary Completion Date

March 29, 2014

Study Completion Date

March 29, 2014

Conditions
Pain
Interventions
DRUG

IBU BID

10-cm strip of IBU 5% topical gel applied to the affected area BID (twice daily) x 3 days

DRUG

Placebo BID

10-cm strip of placebo topical gel applied to the affected area BID (twice daily) x 3 days

DRUG

IBU TID

10-cm strip of IBU 5% topical gel applied to the affected area TID (three times daily) x 3 days

DRUG

Placebo TID

10-cm strip of placebo topical gel applied to the affected area TID (three times daily) x 3 days

Trial Locations (1)

19145

Institute for Applied Pharmaceutical Research, Philadelphia

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01794923 - Topical Ibuprofen for Delayed Onset Mulscle Soreness | Biotech Hunter | Biotech Hunter